Dr. Girish Kulkarni, Urologist, Toronto, ON

Dr. Kulkarni completed his medical school and residency in urology at the University of Toronto. During his residency, he entered the Surgeon Scientist Training Program and completed his PhD in clinical epidemiology through the Institute of Health Policy, Management and Evaluation. He then completed a fellowship in urologic oncology at the Memorial Sloan-Kettering Cancer Center in New York City. Dr. Girish Kulkarni joined the uro-oncology faculty in 2011 and is a urologic surgeon in the Department of Surgical Oncology at the Princess Margaret Cancer Centre, University Health Network. He is also a surgeon-scientist who is affiliated with the Department of Surgery, Faculty of Medicine at the University of Toronto. At the University of Toronto, he is an associate professor in the Department of Surgery, as well as at the Institute of Health Policy, Management and Education. He also holds a senior adjunct scientist position at the Institute for Clinical Evaluative Sciences. Dr. Kulkarni’s main clinical interests are in bladder and prostate cancer. He is also highly involved in the management of “orphan” genitourinary malignancies including urothelial carcinoma of the upper tract and penile carcinoma. Dr. Kulkarni’s primary research interests revolve around the epidemiology of genitourinary malignancies, particularly bladder cancer. His investigations are dedicated towards the understanding of population-level quality of care of urologic malignancies, quality of life and the health economics associated with urologic malignancies. He is also actively involved in clinical trials and is the site principal investigator for numerous non-muscle invasive and muscle invasive bladder cancer trials at the Princess Margaret Cancer Centre. He is an active member of Bladder Cancer Canada and serves on its medical advisory board. Examples of his innovative work in bladder cancer include the development and validation of the Bladder Utility Symptom Scale (BUSS), which is a health related quality of life tool that helps clinicians rapidly measure quality of life in all bladder cancer patients and which will help policy makers determine the cost-effectiveness of bladder cancer treatments. This instrument is being adopted into clinical practice worldwide. He has also promoted the use of bladder-sparing trimodal therapy for patients with muscle invasive bladder cancer and is an established member of the University Health Network’s Multidisciplinary Bladder Cancer Clinic. His work in bladder cancer has been presented at multiple national and international meetings and is currently funded by the Canadian Institutes for Health Research.

is in good standing with the Canadian Urological Society and the Canadian Medical Association

Keywords: Cancer: BPH, Cancer: Prostate Nutrition, Cancer: Breast Cancer, Cancer: Colon and Rectal Cancer Cancer: Lung Cancer, Cancer: Melanoma, Cancer: Ovarian Cancer, Cancer: Prostate Cancer

If you are looking for local services or  treatment froma local urologist   in the office or hospital from a Urologist, contact a provider such as ( Dr. Girish Kulkarni ) to inquire if they are accepting patients or you need a referral.   Phone number to book an appointment 14169799000  ( Dr. Girish Kulkarni ) Is in good standing with the College of Physicians and Surgeons ( Dr. Girish Kulkarni ) Is in good standing with the Canadian Urological Society ( Dr. Girish Kulkarni ) Is in good standing with the Canadian Medical Association

Keywords: Cancer: BPH, Cancer: Prostate Nutrition, Cancer: Breast Cancer, Cancer: Colon and Rectal Cancer Cancer: Lung Cancer, Cancer: Melanoma, Cancer: Ovarian Cancer, Cancer: Prostate Cancer

The speaker in the video may have no association with ( Dr. Girish Kulkarni, Urologist Toronto, ON ). 
( Dr. Girish Kulkarni, Urologist Toronto, ON ), may talk about some of the conditions and some of the treatment options shown on the videos. Always talk with your Local Urologist  about the information you learnt from the videos in regards to Male incontinence Contino® treatments and procedures the Local Urologist  could  perform and if they would be appropriate for you. Remember good information from your Local Urologist  is the corner stone to understanding your condition or disease.

Health Talks:

Sexual preservation for BPH prostate surgery

Urology Practice isa great pleace to start to look into If you’re experiencing symptoms of male incontinence, a local urologist can help. A local urologist can ask about your symptoms and recommend further testing or male incontinence treatment. Urethral inserts like Contino® are temporarily inserted into the urethra (the tube which carries urine to the outside of the body) to prevent or reduce bladder leakage. Damage to the kidneys can lead to swelling in the hands and ankles, high blood pressure, and other symptoms. 

Please contact ( Dr. Girish Kulkarni, Urologist Toronto, ON ) to enquire if this health care provider is accepting new patients. Prostate Cancer NOW is part of the Now Health Network and its focus is on muscular and skeletal  conditions.  In summary, there are many different treatments for prostate cancer.  Identifying the best treatment will depend on your specific situation and your preference after discussion with your doctor. It is not true Asian men have the lowest risk of developing prostate cancer. African men have the highest risk. Often seeing a local urologist in Toronto can help. 

Medications like alpha blockers don't actually treat BPH, they treat the symptoms by relaxing the muscle around the urethra, so thereby reducing some of the resistance.

Sometimes we will add in a second line medication in order to try and shrink the prostate. These medications are called the five alpha reductase inhibitors. So we have Proscar or Avodart These are medications which work by lowering the conversion of testosterone within the prostate. Over a period of 6 to 12 months, this can shrink the prostate by around 20%.